• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Medeikon Presenting New Cardiology Vulnerable Plaque Detection System

Posted on: Monday, 3 October 2005, 09:00 CDT

Medeikon plans to present an overview of our cardiology vulnerable plaque detection system at TCT2005, Transcatheter Cardiovascular Therapeutics, a leading cardiovascular conference, hosted in Washington, D.C. Medeikon's Xplora PD(TM) guidewire probes provide physicians with the information needed to accurately identify coronary disease. Each guidewire probe contains embedded optical sensors that continuously scan into the tissue of the surrounding arterial wall during a routine catheterization procedure.

Xplora PD(TM) sensors use a combination of optical techniques to measure tissue properties in the wall, with depth resolution on the order of 10 microns. Signal processing algorithms are applied that enable the Medeikon Xplora(TM) instrument to obtain an accurate characterization of the wall tissue. With accurate information about the tissue characteristics, physicians may assess the associated risk and make the appropriate treatment decision.

The wall tissue characteristics are presented in real time as a visual map on the accompanying Xplora Console(TM). This system is designed to meet the specific needs of cardiologists through more powerful diagnostic capabilities that allow advanced quantification to make faster and more specific treatment decisions.

Medeikon is currently developing its technology and will license it to medical device manufacturers, pharmaceutical companies and other technology companies. Medeikon is a privately held company.

Source: Business Wire

More News in this Category